Early stage cancer detection research and technology based on the science of metabolomics.
It is our belief that BioMark’s cancer detection technology is an industry disrupter. BioMark will be an integral frontline defense tool in early cancer detection. Metabolomics will be essential for measuring responses to treatment. And Biomark will be a powerful tool for early monitoring of cancer recurrence.
Response to treatment – Companion Diagnostics[CDX]
Monitoring for Cancer Survivors
Screening tool for lung cancer
Complement other high cost, non specific screening technologies
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Canada V6X 2W2
Rashid A. Bux (CEO)
© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.